[1]
“The Role of Oxybutynin Chloride in the Management of Patientswith Benign Prostatic Hyperplasia”, Tikrit J. Pharm. Sci., vol. 4, no. 1, pp. 63–68, Apr. 2023, doi: 10.25130/tjphs.2008.4.8.63.68.